4//SEC Filing
Youssoufian Hagop 4
Accession 0001209191-13-001340
CIK 0001107421other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 5:20 PM ET
Size
7.2 KB
Accession
0001209191-13-001340
Insider Transaction Report
Form 4
Youssoufian Hagop
Executive VP, CMO
Transactions
- Award
Employee Stock Option (right to buy)
2012-12-31+180,000→ 180,000 totalExercise: $4.16Exp: 2022-12-31→ Common Stock (180,000 underlying) - Tax Payment
Common Stock
2012-12-31$4.21/sh−6,919$29,129→ 92,721 total
Footnotes (2)
- [F1]Disposition represents shares withheld to satisfy withholding tax obligations upon the vesting of a restricted stock grant.
- [F2]60,000 shares vest on each of 12/31/2013, 12/31/2014 and 12/31/2015.
Documents
Issuer
ZIOPHARM ONCOLOGY INC
CIK 0001107421
Entity typeother
Related Parties
1- filerCIK 0001525899
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 5:20 PM ET
- Size
- 7.2 KB